Mark A. Hillman
Hillman Value Fund
Hillman Value Fund Portfolio 13F
Mark A. Hillman Holdings Activity
- Portfolio value:
- $172.84M≈ (+$41M≈)
- Previous value:
- $131.62M≈
- # of changes:
- 31
- New positions:
- 4
- Reported for:
- 31 Mar 2021 (Q1)
- Latest filing date:
- 28 May 2021
Hillman Value Fund has disclosed a total of 31 changes to the portfolio in the (2021 Q1) SEC report(s): increased the number of shares of 22, bought 4 totally new and completely sold out 5 position(s).
What stocks did Mark A. Hillman buy in 2021 Q1?
During 2021 Q1 Mark A. Hillman has bought 26 securities out of which top 5 purchases (by % change to portfolio) were (K) Kellanova (added shares +70.52%), (VZ) Verizon Communications Inc (added shares +59.62%), (KHC) Kraft Heinz Co (added shares +21.67%), (BDX) Becton Dickinson and Company (added shares +100.00%) and (CVS) CVS Health Corp (added shares +22.22%).
31 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GlaxoSmithKline PLC ADR
|
new
|
+128,000
|
128,000
|
+3.3%
|
$44.61
|
+14.92%($51.27)
|
3.30%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Alphabet Inc, CL-A
|
new
|
+56,000
|
56,000
|
+3.34%
|
$103.13
|
+263.24%($374.60)
|
3.34%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Amazon.com Inc
|
new
|
+32,000
|
32,000
|
+2.86%
|
$154.70
|
+83.74%($284.26)
|
2.86%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
Magellan Midstream Partners LP
|
new
|
+115,000
|
115,000
|
+2.88%
|
$43.36
|
|
2.88%
|
2021 Q1
|
≈ 0.25 years
|
|
|
|
MONEY MARKET FIDUCIA
|
+270.12%
|
+3,347,286.81
|
4,586,490.61
|
+1.94%
|
$1.00
|
|
2.65%
|
2020 Q1
|
≈ 1.25 years
|
|
|
|
Becton Dickinson and Company
|
+100.00%
|
+12,000
|
24,000
|
+1.69%
|
$243.15
|
-30.45%($169.10)
|
3.38%
|
2020 Q1
|
≈ 1.25 years
|
|
|
|
Meta Platforms Inc
|
+72.73%
|
+8,000
|
19,000
|
+1.36%
|
$294.53
|
+100.47%($590.44)
|
3.24%
|
2020 Q1
|
≈ 1.25 years
|
|
|
|
Kellanova
|
+70.52%
|
+39,700
|
96,000
|
+1.45%
|
$63.30
|
|
3.52%
|
2020 Q1
|
≈ 1.25 years
|
|
|
|
Bristol-Myers Squibb Company
|
+69.57%
|
+32,000
|
78,000
|
+1.17%
|
$63.13
|
+2.75%($64.86)
|
2.85%
|
2020 Q1
|
≈ 1.25 years
|
|
|
|
Pfizer Inc
|
+59.80%
|
+59,500
|
159,000
|
+1.25%
|
$36.23
|
-31.16%($24.94)
|
3.33%
|
2020 Q1
|
≈ 1.25 years
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.